These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35217485)

  • 1. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
    Faraji F; Ahmadi F; Mohaghegh P; Talaie A
    Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran.
    Faraji F; Mohaghegh P; Talaie A
    Mult Scler Relat Disord; 2022 Dec; 68():104231. PubMed ID: 36270251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
    Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
    Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
    Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
    Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence Trend of Gastrointestinal Cancer in Markazi, in the Center of Iran, Population-Based Cancer Registry Results: 2010-2014.
    Taheri M; Nazari J; Anoshirvani AA; Aghabozorgi R; Tabaeian SP; Bahrami M; Almasi-Hashiani A
    J Gastrointest Cancer; 2021 Sep; 52(3):915-921. PubMed ID: 32901447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
    Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
    Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
    Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
    BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
    Almasi-Hashiani A; Sahraian MA; Eskandarieh S
    BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
    Barzegar M; Vaheb S; Mirmosayyeb O; Ashtari F; Afshari-Safavi A; Adibi I; Shaygannejad A; Mazaheri S; Rahimi M; Shaygannejad V
    Mult Scler Relat Disord; 2024 Apr; 84():105479. PubMed ID: 38359695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Maghzi AH
    Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis incidence temporal trend in the Northeast of Iran: Using the Empirical Bayesian method.
    Taghizadeh-Diva SE; Khosravi A; Zolfaghari S; Hosseinzadeh A
    Mult Scler Relat Disord; 2023 Feb; 70():104469. PubMed ID: 36587485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
    Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
    BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study.
    Asmarian N; Sharafi Z; Mousavi A; Jacques R; Tamayo I; Bind MA; Abutorabi-Zarchi M; Moradian MJ; Izadi S
    BMC Neurol; 2021 Aug; 21(1):309. PubMed ID: 34376167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
    Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
    Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
    Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
    Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
    BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
    Cheraghmakani H; Baghbanian SM; HabibiSaravi R; Azar A; Ghasemihamedani F
    PLoS One; 2020; 15(7):e0235562. PubMed ID: 32614900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
    Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
    Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
    Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.